BFS vs CSR

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. Despite a high dividend yield of 7.48%, the unsustainable payout ratio of 207% and declining earnings raise serious concerns. Valuation metrics like a P/E of 27.63 and Price/Book of 5.86 are elevated relative to weak growth and poor profitability trends, while the technical trend score of 0/100 signals strong bearish momentum. Although the analyst target price stands at $44.00, minimal coverage (only one analyst) and deteriorating fundamentals limit confidence in this upside.

CSR exhibits significant fundamental weakness, anchored by a Piotroski F-Score of 4/9 (Stable) and a severe valuation gap where the current price of $66.49 dwarfs both the Graham Number ($31.38) and the Intrinsic Value ($7.14). The company is facing a liquidity crisis with a Quick Ratio of 0.13 and a Current Ratio of 0.44, indicating an inability to cover short-term obligations. Most alarmingly, the dividend payout ratio of 301.96% is unsustainable, suggesting the dividend is being funded by debt or capital reserves rather than earnings. Despite a 'buy' analyst consensus, the combination of stagnant revenue growth (0.30%) and a negative forward P/E makes the current valuation unjustifiable.